Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
C1'-Azacycloalkyl Hexahydrocannabinols.
Ho TC, Shimada N, Tius MA, Nikas SP, Zhang W, Makriyannis A. Ho TC, et al. Among authors: shimada n. J Org Chem. 2017 Aug 4;82(15):7839-7849. doi: 10.1021/acs.joc.7b00988. Epub 2017 Jul 17. J Org Chem. 2017. PMID: 28677397
Neutral Nazarov-type cyclization catalyzed by palladium(0).
Shimada N, Stewart C, Bow WF, Jolit A, Wong K, Zhou Z, Tius MA. Shimada N, et al. Angew Chem Int Ed Engl. 2012 Jun 4;51(23):5727-9. doi: 10.1002/anie.201201724. Epub 2012 Apr 26. Angew Chem Int Ed Engl. 2012. PMID: 22539448 Free PMC article.
Enantioselective palladium(0)-catalyzed Nazarov-type cyclization.
Kitamura K, Shimada N, Stewart C, Atesin AC, Ateşin TA, Tius MA. Kitamura K, et al. Among authors: shimada n. Angew Chem Int Ed Engl. 2015 May 18;54(21):6288-91. doi: 10.1002/anie.201500881. Epub 2015 Apr 1. Angew Chem Int Ed Engl. 2015. PMID: 25833716
Asymmetric Nazarov Cyclizations.
Shimada N, Stewart C, Tius MA. Shimada N, et al. Tetrahedron. 2011 Aug 19;67(33):5851-5870. doi: 10.1016/j.tet.2011.05.062. Tetrahedron. 2011. PMID: 21857751 Free PMC article. No abstract available.
An organocatalytic asymmetric Nazarov cyclization.
Basak AK, Shimada N, Bow WF, Vicic DA, Tius MA. Basak AK, et al. Among authors: shimada n. J Am Chem Soc. 2010 Jun 23;132(24):8266-7. doi: 10.1021/ja103028r. J Am Chem Soc. 2010. PMID: 20507121 Free PMC article.
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab.
Persano M, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Rossari F, Yoo C, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Bergamo F, Amadeo E, Vitiello F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Iavarone MA, Cabibbo G, Montes M, Foschi FG, Vivaldi C, Soldà C, Sho T, Niizeki T, Nishida N, Steup C, Bruccoleri M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Hiraoka A, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Foti S, Camera S, Piscaglia F, Scartozzi M, Cascinu S, Casadei-Gardini A. Persano M, et al. Among authors: shimada n. Target Oncol. 2024 Apr 30. doi: 10.1007/s11523-024-01061-0. Online ahead of print. Target Oncol. 2024. PMID: 38689194
1,328 results